Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers

By Huang Cheng-long   Yokomise Hiroyasu   Miyatake Akira  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 83-93

Future Medicine

Access to resources Recommend Favorite

The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer

By Gregorc V.   Darwish S.   Ludovini V.   Pistola L.   De Angelis V.   Mihaylova Z.   Bellezza G.   Sidoni A.   Cavaliere A.   Bucciarelli E.   Massaro G.   Tonato M.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 275-281

Elsevier

Access to resources Recommend Favorite

The expressions and clinical significance of P53, C-erbB-2 and VEGF in non-small cell lung cancer

By Gu Aiqin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 78-80

Springer Publishing Company

Access to resources Recommend Favorite

bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma

By Fontanini G.   Boldrini L.   Vignati S.   Chine S.   Basolo F.   Silvestri V.   Lucchi M.   Mussi A.   Angeletti C.A.   Bevilacqua G.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 718-723

Elsevier

Access to resources Recommend Favorite

Prognostic value of PD‐L1 expression in combination with CD8⁺ TILs density in patients with surgically resected non‐small cell lung cancer

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 32-45

John Wiley & Sons Inc

Access to resources Recommend Favorite